Paris, 6 – 8 November, 2017
Chromatin and methylation mechanisms
in development and disease
The Epigenetics Workshop-2017 explores the diverse ways through which DNA methylation, histone methylation and other chromatin modifications are linked, and how they control diverse biological functions.
This 3-days’ workshop in Paris, on 6-8 November 2017, brings together twenty five leading scientists in this rapidly evolving field, predominantly from France and Japan. It provides a unique opportunity for international exchange and collaboration.
The workshop is structured around four themes, each of which is introduced by a Keynote Lecture.
The first session considers the regulatory complexes involved in the establishment, maintenance and recognition of chromatin methylation.
Session 2 continues on this theme and discusses the developmental regulation and role of these epigenetic processes in animals and plants.
During the last years, the germ line lineage has been explored in detail, both in Japan and Europe, with many important mechanistic insights, and this constitutes the theme of Session 3.
During the third day (Session 4) the emphasis will be on the relevance of histone and DNA methylation for human disease and cancer. It presents studies in model organisms and examples of how mechanistic insights are being applied to understand and treat epigenetic diseases and cancer.
Importantly, several slots have been allocated for short talks (based on abstract selection) and poster presentations are welcomed and included in the programme as well.
Pierre-Antoine DEFOSSEZ, Ph.D.
Research Director, Epigenetics & Cell Fate Centre, CNRS, University Paris-Diderot, France. Head ‘DNA Dynamics of the Eukaryotic Genome’ laboratory.
Robert FEIL, Ph.D.
Research Director, IGMM, CNRS and University of Montpellier, France.
Head ‘Genomic Imprinting and Development’ laboratory.
Hiroyuki SASAKI, M.D., Ph.D.
Professor, Molecular Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Head ‘Division of Epigenomics and Development’.
Professor Yoichi SHINKAI, Ph.D.
Chief Scientist, RIKEN Institute, Wako, Saitama, Japan.
Head ‘Cellular Memory Laboratory’.
Slimane AIT-SI-ALI (CNRS, Paris)
Déborah BOURC’HIS (Institut Curie, Paris)
Vincent COLOT (CNRS, Paris)
Pierre-Antoine DEFOSSEZ (IGH, CNRS)
Jérôme DÉJARDIN (IGH, CNRS)
Sandra DUHARCOURT (CNRS, Paris)
Robert FEIL (IGMM, Montpellier)
Claire FRANCASTEL (CNRS, Paris)
Daniel GRIMANELLI (IRD, Montpellier)
Petra HAJKOVA (MRC, London)
Zdenko HERCEG (IARC, Lyon)
Tetsuji KAKUTANI (University of Tokyo)
Yutaka KONDO (Aichi Cancer Center, Nagoya)
Atsuji KANEDA (University of Chiba)
Saadi KHOCHBIN (INSERM, Grenoble)
Haruhiko KOSEKI (RIKEN, Yokohama)
Raphaël MARGUERON (Institut Curie, Paris)
Fumihito MIURA (Kyushu University, Fukuoka)
Kazufumi MOCHIZUKI (IGH, Montpellier)
Yuki OKADA (University of Tokyo, Tokyo)
Gilles SALBERT (CNRS, Rennes)
Hiroyuki SASAKI (Kyushu University, Fukuoka)
Yoichi SHINKAI (RIKEN, Wako)
Irina STANCHEVA (Wellcome Trust Centre, Edinburgh)
Kiyoe URA (University of Chiba)
Toshikazu USHIJIMA (National Cancer Institute, Tokyo)
Michael WEBER (Ecole de Biotechnologies, Illkirch)